MRNA Synthesis Service Market Outlook 2026-2034: by Service Type (Custom mRNA Synthesis, GMP-grade Manufacturing, Raw-Material & Enzyme Supply, Design & Optimisation Services, Analytical & QC Services), Application, Scale, End-User

The MRNA Synthesis Service Market is estimated at US$7.7 billion in 2026 and is projected to grow at a CAGR of 7.6% to reach US$13.8 billion by 2034.

Market Overview

The MRNA Synthesis Service Market covers outsourced services that support design, template preparation, synthesis, purification, and analytical characterization of messenger ribonucleic acid products for research and development. Its value chain spans suppliers, manufacturers, service partners, channels, and users across preclinical research, vaccine programs, therapeutic development, analytical support, and early stage process optimization.

Current direction reflects faster turnaround, customized synthesis, integrated analytics, and stronger support for specialized payload design and early development flexibility. Competition includes contract research organizations, specialized synthesis providers, biotechnology service companies, and integrated development partners, with differentiation tied to reliability, usability, technical depth, and support quality.

Market Segmentation

By Service Type

• Custom mRNA Synthesis
• GMP-grade Manufacturing
• Raw-Material & Enzyme Supply
• Design & Optimisation Services
• Analytical & QC Services

By Application

• Vaccines
• Oncology Therapeutics
• Rare-Disease / Protein-Replacement
• Gene-Editing / CRISPR
• Other Therapeutics

By Scale

• Research Grade (RUO)
• Pre-clinical Grade
• Clinical GMP (Phase I-III)
• Commercial GMP
• On-Site Modular Production

By End-User

• Biotechnology Companies
• Pharmaceutical Companies
• CDMOs & CROs
• Others

Key Companies Analysed

• TriLink BioTechnologies
• Aldevron
• Cytiva
• Thermo Fisher Scientific
• Merck KGaA
• Danaher
• Eurofins Scientific
• WuXi AppTec
• ReciBioPharm
• Nitto Avecia
• ST Pharm
• Bio-Synthesis
• Bioneer
• Creative Biolabs
• eTheRNA
• Evonik
• Sartorius
• Lonza
• Curia
• AGC Biologics

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.